Cover image of eliglustat (Cerdelga®) outcome statement


Life Saving Drugs Program – Eliglustat (Cerdelga®) outcome statement

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date: 
26 October 2020
Last updated: 
3 February 2021
Publication type: 
Intended audience: 
General public

The Life Saving Drugs Program Expert Panel considered this application from Sanofi-Aventis Australia Pty Ltd on 15 November 2019. They deferred their decision until the Government-agreed outcomes from the Gaucher disease LSDP medicines review are known.